Hypertension and cardiovascular risk: General aspects

被引:387
|
作者
Kjeldsen, Sverre E. [1 ]
机构
[1] Univ Oslo Hosp, Dept Cardiol, N-0407 Oslo, Norway
关键词
Blood pressure; Cardiovascular risk; Cerebral stroke; Hypertension; Target organ damage; Renal disease; SYSTOLIC BLOOD-PRESSURE; EUROPEAN-SOCIETY; TASK-FORCE; STROKE; FRAMINGHAM; MORTALITY; SCORE; PREVALENCE; DISEASE; AGE;
D O I
10.1016/j.phrs.2017.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is the strongest or one of the strongest risk factors for almost all different cardiovascular diseases acquired during life, including coronary disease, left ventricular hypertrophy and valvular heart diseases, cardiac arrhythmias including atrial fibrillation, cerebral stroke and renal failure. The continuous relationship between blood pressure and cardiovascular and renal events makes the distinction between high normal blood pressure and hypertension based on arbitrary cut-off values for blood pressures. Overall the prevalence of hypertension in different European countries appears to be around 30-45% of the general population, with a steep increase with ageing. The prevention of cardiovascular disease and treatment recommendations should be related to quantification of total cardiovascular risk which could be estimated from several different models. However the impact of age on risk is so strong that young adults (particularly women) are unlikely to reach high-risk levels even when they have more than one major risk factor and a clear increase in relative risk. Therefore age-adjusted models, models assessing relative risks compared to others of same age and models including thorough assessments of target organ damage and ambulatory 24 h blood pressure are needed together with national models because of the large variations between countries. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [21] Cardiovascular Risk in Children: Focus on Pathophysiological Aspects
    Genovesi, Simonetta
    Parati, Gianfranco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18)
  • [22] Elevated heart rate and cardiovascular risk in hypertension
    Mancia, Giuseppe
    Masi, Stefano
    Palatini, Paolo
    Tsioufis, Costas
    Grassi, Guido
    JOURNAL OF HYPERTENSION, 2021, 39 (06) : 1060 - 1069
  • [23] Lung function and cardiovascular risk at age 45 in a cohort of the general population
    Divinagracia, Janelle Ruth C.
    Dummer, Jack
    Hancox, Robert J.
    RESPIRATORY MEDICINE, 2024, 222
  • [24] Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk
    Vaura, Felix
    Kauko, Anni
    Suvila, Karri
    Havulinna, Aki S.
    Mars, Nina
    Salomaa, Veikko
    Cheng, Susan
    Niiranen, Teemu
    HYPERTENSION, 2021, 77 (04) : 1119 - 1127
  • [25] Hypertension and Related Cardiovascular Disease Burden in China
    Bundy, Joshua D.
    He, Jiang
    ANNALS OF GLOBAL HEALTH, 2016, 82 (02): : 227 - 233
  • [26] Second-hand smoking, hypertension and cardiovascular risk: findings from Peru
    Bernabe-Ortiz, Antonio
    Carrillo-Larco, Rodrigo M.
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [27] Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General Mediterranean Population
    Elosua-Bayes, Marc
    Marti-Lluch, Ruth
    del Mar Garcia-Gil, Maria
    Camos, Lourdes
    Comas-Cufi, Marc
    Blanch, Jordi
    Ponjoan, Anna
    Alves-Cabratosa, Lia
    Elosua, Roberto
    Grau, Maria
    Marrugat, Jaume
    Ramos, Rafel
    REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (06): : 458 - 465
  • [28] Kidney Measures with Diabetes and Hypertension on Cardiovascular Disease: The Atherosclerosis Risk in Communities Study
    Alexander, Nadine
    Matsushita, Kunihiro
    Sang, Yingying
    Ballew, Shoshana
    Mahmoodi, Bakhtawar K.
    Astor, Brad C.
    Coresh, Josef
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (4-5) : 409 - 417
  • [29] Hypertension and Cardiovascular Risk Profile in a Middle-Income Setting: The HELISUR Study
    Diemer, Frederieke S.
    Baldew, Se-Sergio M.
    Haan, Yentl C.
    Aartman, Jet Q.
    Karamat, Fares A.
    Nahar-van Venrooij, Lenny M. W.
    van Montfrans, Gert A.
    Oehlers, Glenn P.
    Brewster, Lizzy M.
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (11) : 1133 - 1140
  • [30] Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study
    Zhang, Yuquing
    Zhang, Xuezhong
    Liu, Lisheng
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2010, 28 (10) : 2016 - 2025